Partial agonist properties of rauwolscine and yohimbine for the inhibition of adenylyl cyclase by recombinant human 5-HT1A receptors
- 9 June 1993
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 45 (11), 2337-2341
- https://doi.org/10.1016/0006-2952(93)90208-e
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Expression in animal cells of the 5‐HT1A receptor by a vaccinia virus vector systemFEBS Letters, 1992
- Dual couplings of the cloned 5-HT1A receptor to both adenylyl cyclase and phospholipase C is mediated via the same Gi proteinCellular Signalling, 1991
- [3H]Rauwolscine behaves as an agonist for the 5-HTa receptors in human frontal cortex membranesEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Short-term regulation of Na+/K+ adenosine triphosphatase by recombinant human serotonin 5-HT1A receptor expressed in HeLa cells.Journal of Clinical Investigation, 1990
- Brain 5-HT1A receptor agonism: a novel mechanism for antihypertensive actionTrends in Pharmacological Sciences, 1990
- The genomic clone G-21 which resembles a β-adrenergic receptor sequence encodes the 5-HT1A receptorNature, 1988
- Heterogeneos 3H-rauwolscine binding sites in rat cortex: Two alpha2-adrenoceptor subtypes or an additional non-adrenergic interaction?Life Sciences, 1988
- An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteinsNature, 1987
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973